CARBOLITH
Identification of Carbolith
| No description |
Google image searchProduct monograph
Active ingredient
lithium carbonate, 600 MG
DIN: 02011239
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 03-JUN-2019
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05A — ANTIPSYCHOTICS (ATC, ATC/DDD)
- N05AN — Lithium (ATC, ATC/DDD)
- N05AN01 — LITHIUM (ATC/DDD)
Reference brand drug: Carbolith, Duralith, Lithane
Pharmaceutical standard: USP
